Samyang Biopharmaceuticals Corporation
Quick facts
Marketed products
Phase 3 pipeline
- Genexol® · Oncology
Genexol is a paclitaxel-based nanoparticle formulation that delivers the chemotherapy agent to cancer cells while reducing systemic toxicity.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Samyang Biopharmaceuticals Corporation portfolio CI brief
- Samyang Biopharmaceuticals Corporation pipeline updates RSS
Frequently asked questions about Samyang Biopharmaceuticals Corporation
What are Samyang Biopharmaceuticals Corporation's marketed drugs?
Top marketed products include 0.075% capsaicin cream.
What is Samyang Biopharmaceuticals Corporation's pipeline?
Samyang Biopharmaceuticals Corporation has 1 drugs in Phase 3, 0 in Phase 2, 6 in Phase 1. Late-stage candidates include Genexol®.
Related
- 0.075% capsaicin cream
- Sector hub: All tracked pharma companies